107 related articles for article (PubMed ID: 8067182)
1. [Use of rHu GM-CSF (Leucomax) in treatment of neutropenia during intensive chemotherapy for acute lymphoblastic leukemia].
Rokicka-Milewska R; Derulska D; Pawelec K
Acta Haematol Pol; 1994; 25(2):111-8. PubMed ID: 8067182
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of acute leukemia in children].
Rokicka-Milewska R; Pawelec K; Bogusławska-Jaworska J; Chybicka A; Rosińska B; Stańczak E; Matysiak M; Sońta-Jakimczyk D; Bubała H; Kołecki P; Boruczkowski D; Wysocki M; Kurylak A
Wiad Lek; 1998; 51 Suppl 4():59-64. PubMed ID: 10731945
[TBL] [Abstract][Full Text] [Related]
3. [The use of hematopoietic growth factors G-CSF/GM-CSF in the treatment of neutropenia in children with acute lymphoblastic leukemia and non-Hodgkin's lymphomas].
Nowak K; Pekacka K; Trelińska J; Stolarska M; Bodalski J
Wiad Lek; 1998; 51 Suppl 4():237-42. PubMed ID: 10731975
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony stimulating factor treatment of febrile neutropenia following remission induction chemotherapy for acute leukemia.
Cucuianu A; Petrov L; Ghiurt A; Vasilache A
Rom J Intern Med; 1996; 34(1-2):97-103. PubMed ID: 8908636
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of solid tumors in children. Report of Polish Pediatric Leukemia/Lymphoma Treatment Group].
Chybicka A; Bogusławska-Jaworska J; Rosińska B; Wecławek-Tompol J; Armata J; Balcerska A; Balwierz W; Bubała H; Drabko K; Eliasińska A; Kedziora M; Kołecki P; Kowalczyk J; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sopyło B; Stefaniak MJ; Stańczak E; Stencel D; Wysocki M
Wiad Lek; 1998; 51 Suppl 4():65-71. PubMed ID: 10731946
[TBL] [Abstract][Full Text] [Related]
8. [Administration of granulocyte-macrophage colony growth factors in the treatment of postcytostatic myelosuppresion in oncohematologic patients].
Neuwirtová R; Sisková M; Kvasnicka J; Cmunt E; Benesová E; Klamová H
Cas Lek Cesk; 1994 Aug; 133(16):500-4. PubMed ID: 7923328
[TBL] [Abstract][Full Text] [Related]
9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in an intensive treatment program for children with Ewing's sarcoma.
Luksch R; Massimino M; Cefalo G; Lombardi F; Ferrari A; Casanova M; Gandola L; Terenziani M; Spreafico F; Fossati-Bellani F
Haematologica; 2001 Jul; 86(7):753-60. PubMed ID: 11454532
[TBL] [Abstract][Full Text] [Related]
11. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
[TBL] [Abstract][Full Text] [Related]
12. [The effectiveness of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of non-Hodgkin's lymphoma in children. Report of Polish Pediatric Leukemia/Lymphoma Treatment Group].
Chybicka A; Bogusławska-Jaworska J; Rosińska B; Wecławek-Tompol J; Armata J; Balcerska A; Balwierz W; Bubała H; Drabko K; Eliasińska A; Kedziora M; Sońta-Jakimczyk D; Sopyło B; Kołecki P; Kowalczyk J; Matysiak M; Rokicka-Milewska R; Stefaniak MJ; Stańczak E; Stencel D; Wysocki M; Płoszyńska A
Wiad Lek; 1998; 51 Suppl 4():72-8. PubMed ID: 10731947
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.
Hofmann WK; Seipelt G; Langenhan S; Reutzel R; Schott D; Schoeffski O; Illiger HJ; Hartmann F; Balleisen L; Franke A; Fiedler F; Huber C; Rasche H; Bergmann L; Ganser A; Pott C; Pasold R; Rudolph C; Ottmann OG; Gökbuget N; Hoelzer D
Ann Hematol; 2002 Oct; 81(10):570-4. PubMed ID: 12424538
[TBL] [Abstract][Full Text] [Related]
14. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation in children with acute myelogenous leukemia: a note of caution.
Calderwood S; Doyle JJ; Hitzler JK; Saunders EF; Freedman MH
Bone Marrow Transplant; 1996 Jul; 18(1):87-91. PubMed ID: 8832000
[TBL] [Abstract][Full Text] [Related]
15. [Granulocyte-macrophage colony-stimulating factor in the treatment of secondary bone marrow suppression in patients with lymphoma. Preliminary report].
Avilés A; Díaz-Maqueo JC; Talavera A; García EL
Arch Invest Med (Mex); 1990; 21(2):133-7. PubMed ID: 2103701
[TBL] [Abstract][Full Text] [Related]
16. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
[TBL] [Abstract][Full Text] [Related]
17. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
Duru F; Ertem U; Taçyildiz N; Kirazli S
J Med; 1995; 26(5-6):241-52. PubMed ID: 8721901
[TBL] [Abstract][Full Text] [Related]
18. [Granulocyte colony-stimulating factor in the treatment of febrile neutropenia].
López-Hernández MA; Jiménez-Alvarado R; Borbolla-Escoboza R; de Diego Flores-Chapa J; Alvarado-Ibarra M; González-Avante M; Trueba-Chrysti ME; Anaya-Cuéllar I
Gac Med Mex; 2000; 136(2):99-105. PubMed ID: 10815320
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human GM-CSF: present clinical results and potential use in oncologic and hematologic disorders.
Jones TC
Bull Cancer; 1991; 78(12):1155-9. PubMed ID: 1786428
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor given before dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP).
Holdsworth MT; Roon R; Ferguson J; Martinez L; Stidley CA; Neidhart JA
Biotechnol Ther; 1993; 4(3-4):183-95. PubMed ID: 8292969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
